fenofibrate has been researched along with Cognition Disorders in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Depression has been identified as a risk factor for dementia among patients with type 2 diabetes mellitus but the cognitive domains and patient groups most affected have not been identified." | 2.78 | Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. ( Akpunonu, BE; Bryan, RN; Gerstein, HC; Horowitz, KR; Johnson, J; Katon, WJ; Launer, LJ; Lovato, LC; Marcovina, S; Miller, ME; Murray, AM; Sullivan, MD; Williamson, J; Yale, JF, 2013) |
| "Pretreatment by simvastatin and fenofibrate prevented CPB-induced endothelial dysfunction." | 1.43 | Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass. ( Amr, G; Azzaoui, R; Bordet, R; Delassus, L; Fossaert, E; Modine, T; Ouk, T; Tailleux, A, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sullivan, MD | 1 |
| Katon, WJ | 1 |
| Lovato, LC | 1 |
| Miller, ME | 1 |
| Murray, AM | 1 |
| Horowitz, KR | 1 |
| Bryan, RN | 1 |
| Gerstein, HC | 1 |
| Marcovina, S | 1 |
| Akpunonu, BE | 1 |
| Johnson, J | 1 |
| Yale, JF | 1 |
| Williamson, J | 1 |
| Launer, LJ | 1 |
| Ouk, T | 1 |
| Amr, G | 1 |
| Azzaoui, R | 1 |
| Delassus, L | 1 |
| Fossaert, E | 1 |
| Tailleux, A | 1 |
| Bordet, R | 1 |
| Modine, T | 1 |
| Ramanan, S | 1 |
| Kooshki, M | 1 |
| Zhao, W | 1 |
| Hsu, FC | 1 |
| Riddle, DR | 1 |
| Robbins, ME | 2 |
| Greene-Schloesser, D | 1 |
| Moore, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Analysis of the Cognitive-behavioral Dysfunctions Profile and the Potential of Neuroplasticity in Patients With Brain Tumors Subjected to Selected Radiotherapy Techniques and the Possibility of Their Compensation by Psycho-physical Training[NCT05192447] | 150 participants (Anticipated) | Interventional | 2021-04-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fenofibrate and Cognition Disorders
| Article | Year |
|---|---|
Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial.
Topics: Cardiovascular Diseases; Cognition Disorders; Depression; Diabetes Mellitus, Type 2; Female; Fenofib | 2013 |
3 other studies available for fenofibrate and Cognition Disorders
| Article | Year |
|---|---|
Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.
Topics: Animals; Avoidance Learning; Cardiopulmonary Bypass; Cerebrovascular Disorders; Cognition Disorders; | 2016 |
The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation.
Topics: Animals; Brain; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Cognition Disorders; Cranial I | 2009 |
Molecular pathways: radiation-induced cognitive impairment.
Topics: Animals; Brain; Brain Neoplasms; Cognition Disorders; Fenofibrate; Humans; Neurogenesis; Peroxisome | 2013 |